Methotrexate
- Product NDC
- 50268-527
- 11-digit product format
- 502680527
- Labeler code
- 50268
- Product ID
- 50268-527_ed854d8c-4c13-f684-e053-2a95a90a4968
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA210040
- Marketing category
- ANDA
- Marketing start
- 2021-05-26
- Marketing end
- 0000-00-00
- Substance
- METHOTREXATE SODIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-527 | METHOTREXATE TABLET [AVPAK] | 3 | Legacy NDC | 20240110_c33e84ba-4c0d-f738-e053-2995a90aa20a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-527-15 | 50268052715 | 50 BLISTER PACK in 1 BOX (50268-527-15) > 1 TABLET in 1 BLISTER PACK (50268-527-11) | 50 blister pack | 2021-05-26 | 0000-00-00 | No | No | Current |